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Abstract 
Background: To assess the 9-year changes of the incidence and characteristics of metabolic syndrome (MetS) in 
Chinese community under the background of dramatically changed environment.
Methods: Two cross-sectional surveys of the general population were carried out in 2005 and 2014 in Dengmin 
and Hongnan villages of Fengcheng community, a newly formed urban community from rural area 10 years ago. All 
permanent adult residents aged 18–80 without active malignant tumors and pregnancy were invited to attend the 
study. They participated in clinical examinations for anthropometric and blood pressure measurements. Fasting blood 
samples were drawn for analysis of lipids and glucose. Presence of MetS was defined based on the IDF/AHA harmo-
nized criteria. MetS z-score was calculated to evaluate the degree of total metabolic disorder.
Results: A total of 1042 subjects in 2005 and 1053 subjects in 2014 were included in the final analysis. The partici-
pants were stratified by gender. The incidence of MetS was higher in 2014 than 2005 in both genders (female, 48.28 
vs 31.61 %; male, 41.12 vs 26.30 %; p value, both <0.001). Of the five MetS components, the FBG and TG levels were 
higher in 2014 than 2005 in both gender, however, the SBP and DBP values were even lower in 2014 than 2005. 
The differences of FBG, blood pressure and lipid levels between 2005 and 2014 still exist after ruling out recognized 
diabetic, hypertensive and dyslipidemic subjects, individually. In MetS subjects, MetS z-score showed the whole 
metabolic profile get worse in 2014 than 2005 in both sex (female, 1.97 ± 2.53 vs 1.74 ± 2.29; male, 2.51 ± 2.79 vs 
1.01 ± 2.38. both P < 0.001). Using 3 abnormal components as a combination, we found the frequency of differ-
ent kinds of combination also changed in MetS subjects. In female, the combination of WC + BP + HDL disorder 
decreased from 29.7 % (2005) to 11.0 % (2014) and WC + FBG + BP disorder became the most popular phenotype 
(18.8 %) in 2014.
Conclusions: The dramatically changed environments have extensive influence on metabolic parameters of local 
residents. More targeted measures need to be taken to meet the serious challenges of metabolic diseases.
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Background
Metabolic syndrome (MetS) is becoming a major pub-
lic health issue [1]. The MetS is a complex of interre-
lated risk factors for cardiovascular disease and diabetes. 
These factors include elevated blood pressure (BP), raised 
fasting blood glucose (FBG), high triglyceride (TG), low 
high-density lipoprotein cholesterol (HDL-C) levels, 
and central obesity (waist circumference, WC). With the 
increasing obesity and sedentary lifestyle during the past 
decade [2–4], MetS had a rising prevalence worldwide, 
including China [5–7].
Traditionally, China society was divided into rural–
urban dual system according to the economic and cul-
tural differences [8]. People living in urban area have 
access to more educational and medical resources, more 
social welfare programs and higher paying jobs than 
those who live in rural communities [9]. A serial of stud-
ies have shown a relatively higher prevalence of MetS in 
urban area than rural area [10–12], although the oppo-
site trend exists [13]. In order to reduce the imbalance 
between rural and urban, Chinese government launched 
the largest-scale urbanization in human history in the 
past two decades. The process of urbanization was 
mainly by two ways: the migrants from rural to urban 
area and in  situ urbanization accompanied by urban 
expansion. The percentage of population living in urban 
areas was 25.84 % in 1990, 35.39 % in 2000, but the num-
ber is 54.7 % by the end of 2014 [14]. This means nearly 
29 % Chinese (approximate 350 million) experienced the 
civilization in the past 20 years. These huge amounts of 
people experienced remarkably changes of economic 
and cultural environments in the transition of urbaniza-
tion. It is pivotal important to know about the influence 
of urbanization on the incidence and characteristics of 
metabolic diseases, but data are scarce in China.
Fengcheng community [15] is located in Southern 
Shanghai, 40  km away from the downtown. This for-
mer rural area began urban construction since 2003 and 
became an urban community in 2009 [16]. The resident 
living in Fengcheng experienced the rapid shift from 
peasant to citizen in recent 10 years. In 2005, we carried 
out a study to screen the incidence of MetS in Fengcheng 
as a sample of rural area. Nine years later, the MetS inci-
dence was resurveyed in this new urban community. The 
aim of this study is to investigate the incidence changes 
of MetS and its components under the background of 
rapid urbanization and provide evidences for the health 





Fengcheng community was regarded as a classical rural 
agriculture area until 2003. At that time, under the back-
ground of fast-going urbanization in China, Fengcheng 
community began urban construction and the former 
villager gradually turned into citizen. In 2005, Deng-
min, Hongnan and Haigang villages of Fengcheng were 
selected by cluster random sampling to screening the 
incidence of MetS in Shanghai suburb [15]. In 2014, 
we carried out a survey (SPECT-China) to determine 
the prevalence of metabolic diseases and risk factors in 
East China (ChiCTR-ECS-14005052, http://www.chictr.
org) [17], in which Dengmin and Hongnan villages were 
chosen again. At that time, the total resident population 
in Fengcheng community was 9505 (female, 4832). All 
the eligible permanent adult residents aged 18–80 from 
each village were invited to attend the study. Individuals 
who were pregnant or had active malignant tumors were 
excluded from the study. Of those, 1053 participants 
agreed and completed the study to give a response rate 
of 90.2 % (in 2014). The study protocol was approved by 
the Ethics Committee of Shanghai Ninth People’s Hos-
pital, Shanghai JiaoTong University School of Medicine. 
All participants provided written informed consent 
before data collection. For participants who were illit-
erate, we obtained written informed consent from their 
proxies.
The two measurements were undertaken by the same 
group of trained investigators and the biochemical 
parameters were tested with same method. Subjects were 
interviewed face-to-face to collect demographic informa-
tion, medical history of coronary heart diseases, diabe-
tes, hypertension and lipid disorders by using pre-tested 
questionnaires. The individuals whose income mainly 
came from field labor were regarded as peasants.
Height and weight were measured to the nearest 0.5 cm 
and 0.1  kg, respectively, with the participants wear-
ing light-weight clothing and without shoes. Body mass 
index (BMI) was calculated as weight in kg divided by 
height in meters. WC was measured on standing partici-
pants midway between the lower edge of the costal arch 
and the upper edge of the iliac crest using a non-elastic 
Trial registration ChiCTR-ECS-14005052, http://www.chictr.org, Survey on Prevalence in East China for Metabolic Dis-
eases and Risk Factors (SPECT-China)
Keywords: Metabolic syndrome, Urbanization, Cross-sectional design, Blood pressure
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tape (to the nearest 0.5  cm). All anthropometric meas-
urements were taken in duplicate and the averages of 
these measurements were used in the analyses.
Resting systolic and diastolic BP was measured three 
times at 1-min intervals using a standard mercury sphyg-
momanometer after a 5-minute rest. The average of the 
second and the third readings were used in the analyses.
Fasting venous blood samples were collected in the 
morning after at least 8  h of fasting. The samples for 
plasma glucose test were collected into vacuum tubes 
with anticoagulant sodium fluoride and centrifuged 
on the spot in 1  h after collection. Blood samples were 
shipped in dry ice to a central laboratory within 2–4 h of 
collection. FPG, HDL-C and TG were analyzed enzymat-
ically using an autoanalyzer. All laboratory equipment 
was calibrated, and blinded duplicate samples were used 
for these analyses.
Definition of metabolic syndrome
MetS was defined based on the IDF/AHA harmonized 
criteria [17]. Thus, positive diagnosis of the syndrome 
was established when at least three of the follow-
ing were present: (1) Waist circumference  ≥90  cm 
in men or  ≥80  cm in women [18]; (2) HDL choles-
terol  <1.0  mmol/L in men or  <1.3  mmol/L in women; 
(3) Serum TGs  ≥1.7  mmol/L (4) Serum glucose 
level ≥5.6 mmol/L; (5) Blood pressure ≥130/85 mmHg. 
Treatment with anti-hypertensive, hypoglycemic or 
lipid-lowering drugs was considered as alternate indi-
cators of the latter three components. To compare 
the incidence difference between 2005 and 2014, age-
standardized incidence rates of MetS were calculated 
using direct standardization with population composi-
tion of the Sixth National Population Census of China 
(2010). In order to exclude the influence of medication 
or other treatment measures after the diagnosis of meta-
bolic diseases, we sorted out the subjects with or with-
out recognized Diabetes Mellitus (DM), hypertension 
and dyslipidemia history for subgroup analysis. The 1999 
World Health Organization (WHO) diagnostic criteria 
were used to diagnose diabetes mellitus [19]. A subject 
with SBP or DBP ≥140/90 mmHg is considered hyper-
tension by WHO/ISH 1999 criteria [20].
MetS z-score was calculated. It takes into account 
continuous changes in each component, representing 
the score of continuous risk for MetS [21]. For each 
risk factor, a z-score was calculated (individual value—
sample mean/standard deviation of the sample). For 
the blood pressure, we used the MAP (2/3 DBP +  1/3 
SBP) of for calculating the score. Total score  =  waist 
Z score  +  BP Z score  +  glucose Z score  +  HDL-C Z 
score  +  triglycerides Z score. A lower risk score is 
indicative of a better metabolic profile.
Statistical analysis
All analyses were stratified by sex. Continuous variables 
are presented as mean ± SD and proportions were calcu-
lated for discrete variables. To test differences in continu-
ous variables between 2005 and 2014, the independent 
sample t test was performed. Associations between nom-
inal variables were performed with the Pearson Chi 
square test. Since the mean age of study participants was 
higher in 2014 than 2005, age-adjusted linear and logis-
tic regression models were used to compare means and 
proportions of different components of the MetS. Gen-
eral linear model were used to evaluate whether the dif-
ference was maintained after controlling for potential 
confounding variables. We normalized FBG by inverse 
transformation and TG by a logarithmic transforma-
tion before evaluated in t test or general linear model. 
Paired t tests were performed to determine any signifi-
cant changes in population attending both surveys. In 
the process of analyzing the frequency of components 
combination of MetS, all kinds of 3-factor combinations 
were counted. The actual frequency of one 3-factor com-
bination is equal to the sum of the number of this combi-
nation in 3-factor group and the number of 4-factor and 
5-factor group including this 3-factor combination [The 
theoretical frequency of total random 3 parameters com-
bination equal to (total 3-factor frequency)*1 plus (total 
4-factor frequency)*4 plus (total 5-factor frequency)*5]. 
Data were analyzed using SPSS software version 22.0 
for Mac, with the significance level set at p < 0.05 for all 
analyses.
Results
A total of 1042 subjects (females, 658) with a mean ± SD 
age of 53.72  ±  12.14  years in 2005 and 1053 subjects 
(females, 642) with age 57.08 ±  12.46 years old in 2014 
were included in the study. All participants were of Han 
origin. From Table 1, the residents still doing agricultural 
work were markedly reduced in 2014 than 2005. Com-
pare with 2005, the percentage of recognized coronary 
heart disease, type 2 DM, hypertension and dyslipidemia 
were much higher in 2014.
In view of different incidence and variable cut-points 
between female and male, we divided the subjects by 
gender in the following analysis. Using the IDF/AHA 
harmonized criteria, the MetS incidence was significantly 
elevated in 2014 than 2005 (female, 48.28 vs 31.61  %; 
male, 41.12 vs 26.30  %; p value, both  <0.001) and these 
differences still exist after accounting for age and BMI. 
In terms of components of MetS, the FBG and TG levels 
were higher in 2014 than 2005 in both sex, however, the 
SBP and DBP values were even lower in 2014 than 2005. 
These differences still exist after adjusting age and BMI. 
WC had a tendency of increment in 2014 but cannot 
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reach statistical significance. The HDL levels were higher 
in 2014 than 2005 in female, but the difference was 
absent in male. The percentage of individual component 
that reached the MetS criteria showed similar trend with 
the continuous variables in both genders (Table 2).
We sorted out the subjects with or without recognized 
DM, hypertension and dyslipidemia history for further 
analysis. From Fig. 1, the FBG, blood pressure and lipid 
levels differences between 2005 and 2014 after ruling out 
recognized type 2 DM, hypertension and dyslipidemia, 
individually, showed similar results with the total sub-
jects in both genders. In patients with recognized type 
2 DM, hypertension and dyslipidemia, the SBP and DBP 
levels in 2014 were still lower than 2005 in hypertensive 
individuals in both genders (P  <  0.05). HDL levels were 
higher in 2014 in female patients with dyslipidemia his-
tory and the male showed the same trend (P  <  0.05). 
The FBG levels had a tendency of decrease in diabetic 
patients in both genders.
In view of the opposite alteration of BP and BG, 
TG and HDL on MetS incidence, we further ana-
lyzed the change of metabolic disorder spectrum in 
the MetS population. From Table  3, the frequency of 
metabolic disorder in male followed the same pat-
tern (BP  >  WC  >  FBG  >  TG  >  HDL), but the fre-
quency of HDL abnormality was lower and glucose 
showed marginal higher in 2014 than 2005. In female, 
because of the markedly increased rate of abnormal 
FBG and TG, together with decreased rate of abnor-
mal BP and HDL, the frequency of metabolic disor-
der changed from (BP  >  WC  >  HDL  >  TG  >  FBG) to 
(WC  >  BP  >  FBG  >  TG  >  HDL). To quantify the total 
impact of metabolic disorder, we calculated the MetS 
z-score and found despite of the frequency change of dif-
ferent components, the whole metabolic profile get worse 
in 2014 than 2005 in both sexes (female, 1.97  ±  2.53 
vs 1.74  ±  2.29; male, 2.51  ±  2.79 vs 1.01  ±  2.38. both 
P < 0.001), these differences still exist after adjusting age.
The clustering of various components was further 
assessed. Additional file  1: Table S1 illustrated meta-
bolic disorder patterns in all MetS subjects. Using 3 
parameters as a combination, we found the combina-
tions of components were similar between 2005 and 
Table 1 General characteristics of  the study population 
in 2005 and 2014
Data were showed as mean ± SD or number of subjects (%)
BMI body mass index, CHD coronary heart disease, DM diabetes mellitus
2005 (n = 1042) 2014 (n = 1053) P value
Gender (female) 658 (63.15) 642 (60.97) NS
Age (years) 53.72 ± 12.14 57.08 ± 12.46 <0.001
Occupation (peasants) 587 (56.33) 254 (24.12) <0.001
BMI (kg/m2) 24.18 ± 3.28 25.26 ± 3.53 <0.001
MetS 309 (29.65) 479 (45.49) <0.001
Recognized diseases
 CHD 34 (3.26) 116 (11.02) <0.001
 Type 2 DM 33 (3.17) 92 (8.74) <0.001
 Hypertension 233 (22.36) 381 (36.18) <0.001
 Dyslipidemia 32 (3.07) 100 (9.50) <0.001
Table 2 Comparison of MetS components between 2005 and 2014
Data were showed as mean ± SD or number of subjects (%). ASR age-standardized incidence rate (using China standard population 2010). Data were showed as 
number of subjects (%) or mean ± SD
Female P value Male P value
2005 (n = 658) 2014 (n = 642) 2005 (n = 384) 2014 (n = 411)
WC (cm) 80.38 ± 8.69 80.89 ± 10.07 0.33 83.91 ± 9.01 84.69 ± 9.64 0.24
FBG (mmol/L) 4.99 ± 1.19 5.88 ± 1.47 <0.001 5.24 ± 1.36 5.99 ± 1.45 <0.001
SBP (mmHg) 139.91 ± 24.61 134.13 ± 22.42 <0.001 143.24 ± 23.56 135.14 ± 19.76 <0.001
DBP (mmHg) 86.45 ± 12.50 79.83 ± 13.69 <0.001 89.92 ± 12.94 80.35 ± 13.23 <0.001
TG (mmol/L) 1.20 ± 0.89 1.56 ± 0.96 <0.001 1.24 ± 0.94 1.80 ± 1.54 <0.001
HDL (mmol/L) 1.38 ± 0.30 1.49 ± 0.32 <0.001 1.34 ± 0.34 1.36 ± 0.31 0.35
Numbers of each component reach MetS criteria (%)
 WC 329 (50) 468 (72.90) <0.001 110 (48.18) 140 (49.88) 0.63
 FBG 94 (14.29) 302 (47.04) <0.001 113 (29.42) 214 (52.06) <0.001
 BP 460 (69.91) 421 (65.58) 0.095 304 (79.17) 289 (70.32) 0.004
 TG 112 (17.02) 192 (29.91) <0.001 75 (19.53) 143 (34.79) <0.001
 HDL 291 (44.22) 192 (29.91) <0.001 47 (12.23) 36 (8.76) 0.11
MetS incidence rate (%)
 Crude 31.61 48.28 <0.001 26.30 41.12 <0.001
 ASR 24.47 36.90 <0.001 25.26 36.49 <0.001
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2014 in male, except the WC + BP + HDL was slightly 
decreased in 2014. However, in female, the phenotype 
of WC  +  BP  +  HDL markedly decreased from 29.7  % 
(2005) to 11.0  % (2014). WC +  FBG +  BP became the 
most frequent combination (18.8 %) in 2014 (Fig. 2).
In 2014, there were 594 residents attended the first sur-
vey (2005). After 9 years, BMI increased significantly in 
both sex but WC only showed slightly rise. FBG, TG and 
HDL concentrations were higher than before except the 
HDL in male showed no difference. SBP and DBP levels 
had a tendency to decline except SBP in female (Table 4).
Discussion
In this study, the changes of metabolic syndrome inci-
dence and its components were explored in a typi-
cal community before and after urbanization. It is not 
Fig. 1 Comparisons of FBG (a), blood pressure (b) and lipid levels (c) between 2005 and 2014 stratified by recognized type 2 DM, hypertension and 
dyslipidemia, individually. *P < 0.05; NS not significant
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surprising that the incidence of MetS is higher over a 
period of 9 years in the same community. The key find-
ing of our study is the higher incidence of MetS was 
mainly attributed to more FBG and TG abnormality, but 
not WC, BP and HDL. The blood pressure and HDL dis-
orders even showed a beneficial change. Eventually, the 
risk factor combination also altered dramatically. These 
unique alterations provide first-hand evidence for the 
health provider to take corresponding actions.
In our study, the incidence of MetS in 2014 was much 
higher than 9 years before. Using MetS z-score, we also 
found the whole metabolic profile got worse in 2014 
than 2005 in MetS subjects. In most developing coun-
tries, the prevalence of MetS is still increasing [6, 22, 23]. 
Fortunately, in some developed area, such as France, had 
showed trend of decline [24]. US also experienced an 
increase from 1990s to 2000s [5] and decreased tendency 
from 25.5  % to 22.9  % (1999/2000 to 2009/2010) [25]. 
Further follow-up is needed in our community to observe 
the possible shift.
One interesting finding of our research is the increased 
incidence of MetS was mainly attributed to more FBG 
and TG disorders. However, the WC did not change sig-
nificantly in both genders. This is different from other 
developing area, in which the increasing prevalence of 
obesity was still regarded as the pivotal cause of MetS 
[22, 26]. Even in US, the prevalence of elevated waist cir-
cumference increased from 45.4 to 56.1  % (1999/2000 
to 2009/2010) [25]. By contrast, the above-mentioned 
France study showed prevalence of abdominal obe-
sity was unchanged (from 1996 to 2006) [24]. In addi-
tion, in our community the BMI increased significantly 
in 2014 compared with 2005, suggesting the increased 
body weight were stored in non-abdominal area. We 
cannot explain our WC data clearly till now and further 
measurement of body fat distribution will be helpful to 
explain current findings [27]. More FBG and TG disor-
ders are similar to other developing area. Excess sugar 
and lipid-rich food intake (classic western food) under 
urbanization may be the underlying cause. However in 
developed country, the hypertriglyceridemia [25] and ele-
vated fasting glucose [24] prevalence showed decreasing 
trends.
The good news for us is the BP and HDL disorders 
decreased significantly (except HDL in male). To our 
knowledge, increased BP was reported almost all large-
scale clinical trials in china. But in most of developed 
area, including Japan [22] and US, BP had showed ten-
dency of decline. Some articles argued this decline was 
related to the antihypertensive medicine. From our data, 
the SBP and DBP levels in 2014 were still lower than 
2005 after ruling out the cases with hypertension history. 
Although we cannot make sure whether our community 
had successfully passed the blood pressure plateau, the 
decrease of BP per se is an exciting result. The reason we 
think could be partly attributed to the lower salt intake 
after life style education. As to higher HDL, Framing-
ham Heart Study found an increase in HDL-C during 
a 10-year period (from 1991 to 2001) [28]. One study 
in Nigeria showed the HDL-C levels was higher among 
urban dwellers than rural dwellers [29]. The NHANES 
analysis illustrated a slight increase of age-adjusted 
HDL-C in women (from 53.8  mg/dL in 1976–1980 to 
55.9 mg/dL in 1999–2002), but not in men. The NHANES 
data also found a borderline significant increase in TG 
levels when restricting their sample to adults aged 20 to 
74 years [30]. These data are quite similar to us. There is 
evidence that the increase in HDL-C and the decrease in 
TG are due to changes in cigarette smoking [31] and car-
bohydrate intake [32]. The exact cause of beneficial HDL 
change in our rapid urbanized community needs further 
investigation.
Another good news is the higher awareness of meta-
bolic disease and better control of hypertension and 
diabetes in 2014 than 2005. We think the reason is more 
extensive medical insurance coverage, more hospital 
and physician service accessibility after the urbanization 
[33].
Table 3 The frequency of abnormal components in MetS subjects between 2005 and 2014
Data were showed as number of subjects (%) or means ± SD
Female MetS P value Male MetS P value
2005 (n = 208) 2014 (n = 310) 2005 (n = 101) 2014 (n = 169)
Abnormal component
 WC 191 (91.83) 288 (92.90) 0.649 88 (87.13) 143 (84.62) 0.57
 FBG 73 (35.10) 234 (75.48) <0.001 66 (65.35) 129 (76.33) 0.051
 BP 202 (97.12) 269 (86.77) <0.001 98 (97.03) 158 (93.49) 0.204
 TG 75 (36.06) 170 (54.84) <0.001 54 (53.47) 107 (63.31) 0.11
 HDL 157 (75.48) 150 (48.39) <0.001 32 (31.68) 30 (17.75) 0.008
 MetS z score 1.74 ± 2.29 1.97 ± 2.53 <0.001 1.01 ± 2.38 2.51 ± 2.79 <0.001
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Fig. 2 Comparison of various components clustering in all MetS subjects between 2005 and 2014
Table 4 Characteristics of the repeatedly surveyed population in 2005 and 2014
Data were showed as mean ± SD or number of subjects (%)
Female (n = 396) P value Male (n = 198) P value
2005 2014 2005 2014
Age (years) 52.30 ± 10.07 61.30 ± 10.07 <0.001 53.80 ± 8.98 62.80 ± 8.98 <0.001
BMI (kg/m2) 24.31 ± 3.28 25.46 ± 3.48 <0.001 24.17 ± 3.03 25.59 ± 3.33 <0.001
WC (cm) 81.30 ± 8.47 81.97 ± 9.63 0.171 83.63 ± 8.54 85.61 ± 9.57 0.002
FBG (mmol/L) 4.93 ± 0.89 6.00 ± 1.45 <0.001 5.21 ± 1.24 6.06 ± 1.48 <0.001
SBP (mmHg) 139.17 ± 22.45 136.67 ± 22.07 0.057 145 ± 23.32 137.42 ± 20.70 <0.001
DBP (mmHg) 87.00 ± 12.90 81.64 ± 14.13 <0.001 91.64 ± 12.82 81.47 ± 13.76 <0.001
TG (mmol/L) 1.21 ± 0.83 1.61 ± 0.96 <0.001 1.21 ± 1.00 1.72 ± 1.44 <0.001
HDL (mmol/L) 1.35 ± 0.28 1.50 ± 0.33 <0.001 1.34 ± 0.35 1.36 ± 0.31 0.414
MetS n (%) 142 (35.9) 193 (48.7) <0.001 52 (26.3) 84 (42.2) <0.001
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The major threat of MetS is its association with 
increased cardiovascular (CV) events and all-cause mor-
tality rates [34]. CV diseases are among the top health 
problems of the Chinese people, and pose a serious chal-
lenge to the public health system [35, 36]. However, the 
relative contribution of the 5 risk factors to the occur-
rence of CV diseases is still unknown. One follow-up 
study illustrated that patient with diabetes suffered from 
significantly increased mortality rate after CABG (coro-
nary artery bypass grafting), but the subjects with MetS 
showed no difference with the matched background 
population [37]. Hypertriglyceridemia is associated with 
a substantially increased long-term total mortality and 
CV risk [38], which is regarded as a potential CV residual 
risk factor [39]. In our community, more glucose and TG 
disorders occurred after 9-year observation. The effects 
of these changes, together with beneficial shift of BP and 
HDL disorders, on the occurrence of CV diseases need 
further follow-up in our community.
Another issue we need to address is the possi-
ble involvement of non-alcoholic fatty liver disease 
(NAFLD). Several studies have independently provided 
evidence for a strong association between NAFLD and 
each component of the metabolic syndrome, including 
central obesity, hyperglycemia, dyslipidemia, and hyper-
tension [40]. The growing glucose and lipid disorders in 
our community may be related to NAFLD.
Although certain components of MetS showed benefi-
cial changes, but the total metabolic profile got worse in 
2014 than 2005. That means the risk of MetS complica-
tions was still higher in 2014. In the components combina-
tion analysis, we found the combination pattern changed 
markedly in female and more female MetS subjects had 
got total five risk factors. It provides important informa-
tion for us to take more specific actions for this group.
Intensive lifestyle intervention or specific nutrient sub-
stitution has been reported to produce benefit in multiple 
metabolic cardiovascular risk factors [41]. In our com-
munity, targeted measures to reduce the TG and FBG 
levels will be the key point to control the rapid increase 
of MetS.
Some limitations need to be addressed in our study. 
First, choosing a rural area without experiencing urban-
ization as control group will be quite helpful to our 
interpretation. Unfortunately, we did not have that 
opportunity. Second, as we mentioned in the introduc-
tion, urbanization includes the migrants from rural to 
urban area and in  situ urbanization accompanied by 
urban expansion. A recently published cross-sectional 
study had showed differences of metabolic risk factors 
between internal migrant workers and general population 
[42]. Our sample was from in  situ urbanization and the 
MetS characteristics of migrants still need further inves-
tigation. Third, large regional gap exists between big cit-
ies (like Shanghai) and other medium or small city, thus 
there must be economic or medical differences after the 
urbanization in different areas. Data from Guangdong 
province in southern China showed similar results on 
prevalence of hyperglycemia and TG from 2002 to 2010 
in rural area, but they did not found the decreased trend 
of BP and HDL [43]. It is important to broaden the sam-
ple size to get more accurate and generalizable results. 
Fourth, other confounders, such as different nationalities, 
socioeconomic position, service availability and residen-
tial density, noise pollution, drugs, diets, physical activity 
may also influence the results [44].
In summary, our study present a unique scenario of the 
characteristics of MetS under the rapid urbanization in 
China, but the reasons underlying are complex. On the 
one hand, the higher incidence and more FBG and TG 
disorders still needed more efforts to deal with, on the 
other, the beneficial changes of blood pressure and HDL 
and the more awared and better controlled diabetes and 
hypertension mean brilliant prospects of urbanization to 
rural Chinese people. The local government needs to take 
corresponding measures to help the old residents adjust 
the new urbanized environment.
Conclusions
The dramatically changed environments have extensive 
influence on metabolic parameters in the inhabitant Chi-
nese people. More targeted measures need to be taken to 
meet the serious challenges of metabolic diseases.
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